Diagnostic Approach for Pulmonary Embolism in Cancer Patients

Diagnostic Testing

• The European Society of Cardiology recommends CTPA as the preferred diagnostic test for suspected PE in cancer patients, providing direct visualization of pulmonary arterial thrombi 1, 2, 3
• The National Comprehensive Cancer Network recommends ventilation/perfusion scanning as an alternative to CTPA when it is contraindicated, such as in cases of renal insufficiency or contrast allergy 2
• Magnetic resonance angiography with contrast is another alternative imaging option when CTPA cannot be performed, as suggested by the National Comprehensive Cancer Network 2

Role of D-Dimer Testing

• The European Respiratory Society states that D-dimer testing has severely limited diagnostic utility in cancer patients and should generally be avoided due to its high false-positive rate 1, 3, 5
• The European Heart Journal notes that D-dimer is frequently elevated in cancer patients regardless of VTE status, with a number needed to test rising from 3 in general emergency department populations to ≥10 in cancer patients 1, 3, 5

Clinical Probability Assessment

• The European Heart Journal recommends using validated clinical prediction rules, such as the Wells score or revised Geneva score, to stratify pre-test probability before ordering imaging 1, 3, 6
• The Annals of Internal Medicine suggests that the Wells score assigns 2 points for active cancer, defined as treatment within 6 months or palliative care 1, 6

Management of Incidental PE

• The European Heart Journal recommends that incidental PE discovered on imaging performed for other reasons should be managed identically to symptomatic PE when involving segmental or more proximal branches, multiple subsegmental vessels, or single subsegmental vessel with proven DVT, with a Class IIa indication and Level B evidence 2, 7, 8

Critical Pitfalls to Avoid

• The National Comprehensive Cancer Network advises against relying on D-dimer alone to exclude PE in cancer patients due to its high false-positive rate 2, 5
• The European Heart Journal recommends against delaying CTPA while waiting for D-dimer results in cancer patients with intermediate or high clinical probability 5
• The National Comprehensive Cancer Network suggests considering initiating early anticoagulation while awaiting imaging results in cases with high suspicion of PE and no contraindications 2